-
-
-
-
G610748-25mgguanethidine.
-
G610748-5mgguanethidine.
-
G610752-25mgguanylpirenzepine.
-
G610752-5mgguanylpirenzepine.
-
G610755-25mggunagratinib.
-
-
G412595-10mgInformationGusacitinib (ASN-002) is an orally active and potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 of 5-46 nM. Gusacitinib has anti-cancer activity.
-
G412595-25mgInformationGusacitinib (ASN-002) is an orally active and potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 of 5-46 nM. Gusacitinib has anti-cancer activity.
-
G412595-50mgInformationGusacitinib (ASN-002) is an orally active and potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 of 5-46 nM. Gusacitinib has anti-cancer activity.